| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/02/2009 | WO2008124000A3 Thiazole derivatives as androgen receptor modulator compounds |
| 04/02/2009 | WO2008104994A3 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 04/02/2009 | WO2008005914A3 Novel glucokinase activators and methods of using same |
| 04/02/2009 | US20090088490 Two-photon absorption recording material containing dye having polymerizable group |
| 04/02/2009 | US20090088457 Primary Amines as Renin Inhibitors |
| 04/02/2009 | US20090088456 2-Pyridinylethylcarboxamide derivatives and their use as Fugicides |
| 04/02/2009 | US20090088452 Indole Orexin Receptor Antagonists |
| 04/02/2009 | US20090088450 5-ht7 receptor antagonists |
| 04/02/2009 | US20090088422 4-imidazolin-2-one compounds |
| 04/02/2009 | US20090088420 Compounds with hiv-1 integrase inhibitory activity and use thereof as anti-hiv/aids therapeutics |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700539A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | CA2700113A1 Indazole acrylic acid amide compound |
| 04/02/2009 | CA2699787A1 (3-hydroxy-4-amino-butan-2-yl)-3-(2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating |
| 04/02/2009 | CA2699718A1 Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
| 04/02/2009 | CA2699328A1 Pyrrolidines and piperidines as orexin receptor antagonists |
| 04/01/2009 | EP2042499A1 Salt of morpholine compound |
| 04/01/2009 | EP2042494A1 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof |
| 04/01/2009 | EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists |
| 04/01/2009 | EP2042173A2 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 04/01/2009 | EP2042171A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 04/01/2009 | EP2041129A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 04/01/2009 | EP2041126A1 Indole compounds having affinity to the ep1 receptor |
| 04/01/2009 | EP2041125A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 04/01/2009 | EP2041124A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
| 04/01/2009 | EP2041116A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 04/01/2009 | EP2041113A1 Novel pyridazine derivatives |
| 04/01/2009 | EP2041103A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 04/01/2009 | EP2041102A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 04/01/2009 | EP2041089A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 04/01/2009 | EP2041086A1 Indole compounds |
| 04/01/2009 | EP2040690A1 Inhibitors of cxcr2 |
| 04/01/2009 | EP1638960A4 Preparation of chemical compounds |
| 04/01/2009 | CN101400673A Heterobicyclic carboxamides as inhibitors for kinases |
| 04/01/2009 | CN101400662A Substituted isoxazoline compound and pest control agent |
| 04/01/2009 | CN101397297A Aminothiazole derivates, preparation method and use thereof |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 04/01/2009 | CN100473648C 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 04/01/2009 | CN100473381C Use of epothilones in the treatment of brain diseases associated with proliferative processes |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511148 Process for preparing thiazolidinediones |
| 03/31/2009 | US7511145 Bicyclic heteroaryl derivatives |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511135 Reacting2-(2-aminothiazol-4-yl)-2-methyloxyiminoacetic acid-2-benzothiazolyl thioester; then with sodium 2-ethylhexanoic; purity; stability |
| 03/31/2009 | US7511071 Thioamide derivatives as progesterone receptor modulators |
| 03/31/2009 | US7511066 Antithrombotic aromatic ethers |
| 03/31/2009 | US7511062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
| 03/31/2009 | US7511059 Thiazolidinones, their production and use as pharmaceutical agents |
| 03/31/2009 | US7511045 Dihydrothienopyrimidines; gastrointestinal disorders; cancer |
| 03/31/2009 | US7511044 Vanilloid receptor ligands and their use in treatments |
| 03/31/2009 | US7511038 Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors |
| 03/31/2009 | US7510700 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 03/26/2009 | WO2009039328A1 Pyridyl sulfonamides as modulators of ion channels |
| 03/26/2009 | WO2009039134A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | WO2009039127A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | WO2009038974A1 Compounds and compositions as modulators of gpr119 activity |
| 03/26/2009 | WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/26/2009 | WO2009038157A1 2,3-dihydroiminoisoindole derivative |
| 03/26/2009 | WO2009038064A1 Heterocyclic derivative having inhibitory activity on type-i 11β-hydroxysteroid dehydrogenase |
| 03/26/2009 | WO2009037357A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | WO2009037302A1 5-substituted-1, 4-benz0diazepines as phosphodiesterase inhibitors |
| 03/26/2009 | WO2009037247A1 Pyrazine derivatives and their use as potassium channel modulators |
| 03/26/2009 | WO2009037244A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | WO2009037222A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | WO2009036996A2 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | WO2009036766A1 Cyanoisoquinoline |
| 03/26/2009 | WO2009016564A3 2-aza-bicyclo[3.3.0]octane derivatives |
| 03/26/2009 | WO2009016560A3 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2008139288A3 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 03/26/2009 | WO2008121415A3 Improved process for preparing quetiapine fumarate |
| 03/26/2009 | WO2008042422A3 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082560 Aminodihydrothiazine derivatives |
| 03/26/2009 | US20090082406 Cancer Therapy |
| 03/26/2009 | US20090082405 Deuterium-enriched pioglitazone |
| 03/26/2009 | US20090082392 Substituted Carboxylic Acids |
| 03/26/2009 | US20090082390 Piperidine compounds for use as orexin receptor antagonist |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082334 Deuterium-enriched quetiapine |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | CA2700051A1 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | CA2699986A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | CA2699981A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | CA2699892A1 Pyridyl sulfonamides as modulators of ion channels |
| 03/26/2009 | CA2699817A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | CA2698527A1 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | CA2697551A1 Piperidine derivatives as modulators of gpr119 activity |
| 03/26/2009 | CA2696508A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | CA2691474A1 Cyanoisoquinoline |
| 03/26/2009 | CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/25/2009 | EP2039694A1 CGRP receptor antagonists |
| 03/25/2009 | EP2039690A1 3,4-dihalogenoisothiazole derivative and agent for controlling agricultural or horticultural plant disease |
| 03/25/2009 | EP2039687A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 03/25/2009 | EP2039686A1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases |
| 03/25/2009 | EP2038278A2 Thiazoline and oxazoline derivatives and their methods of use |